Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
A Study of Brentuximab Vedotin, Rituximab, and Dose Attenuated CHP in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT02734771. IPD Sharing: NO. Countries: 1. Publications: 0.
Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial)
ClinicalTrials.gov study NCT07166549. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
ClinicalTrials.gov study NCT05442515. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of JMT601 in Participants With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06725524. IPD Sharing: NO. Countries: 1. Publications: 0.
CD19/20 Bispecific Nanobody-derived CAR-T Cells in B Cell Lymphoma
ClinicalTrials.gov study NCT03881761. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19-targeting CAR T Cells in Relapsed or Refractory CD19 Positive B-cell Malignancies
ClinicalTrials.gov study NCT03559439. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Disease Activity and Modulation of Synovial Lymphoid Structures and B Cell Function in Rheumatoid Arthritis
ClinicalTrials.gov study NCT02528292. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Double-blind, Randomized Controlled Study in CD20-positive Diffuse B Cell Non-Hodgkin's Lymphoma Subjects
ClinicalTrials.gov study NCT01205737. IPD Sharing: Not stated. Countries: 10. Publications: 0.
Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology
ClinicalTrials.gov study NCT00950755. IPD Sharing: YES. Countries: 0. Publications: 0.
Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)
ClinicalTrials.gov study NCT01435720. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Loncastuximab Tesirine for the Treatment of Relapsed or Refractory B-Cell Malignancies
ClinicalTrials.gov study NCT05453396. IPD Sharing: NO. Countries: 1. Publications: 0.
Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL
ClinicalTrials.gov study NCT00180895. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06295549. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I Trial to Establish the Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric Antigen Receptor (CAR) T-cells in Patients With Relapsed and Refractory B-cell Ma
ClinicalTrials.gov study NCT05836896. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of Chronic Lymphocytic B-Leukemia With IL-2 and CD-40 Autologous Tumor Cells
ClinicalTrials.gov study NCT00058786. IPD Sharing: Not stated. Countries: 1. Publications: 0.
B Cell Maturation Antigen Targeted CAR-T Cells in Treatment With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05150522. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
ClinicalTrials.gov study NCT05618028. IPD Sharing: NO. Countries: 10. Publications: 0.
A Safety, Tolerability, Pharmacokinetics and Efficacy Study of GB261 in B-Cell NHL and CLL.
ClinicalTrials.gov study NCT04923048. IPD Sharing: NO. Countries: 1. Publications: 0.
Lenalidomide and R-CHOP in B-cell Lymphoma
ClinicalTrials.gov study NCT00901615. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19 CAR-T Therapy for Patients With B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT04661020. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.